Loading viewer...
earnings
Format: PDF earnings
Lenzing AG presents Q1 2023 financial results showing early signs of market recovery with revenue of EUR 623 million and EBITDA of EUR 30 million. The company highlights successful cost reduction initiatives, production expansion in China, and strategic acquisitions while confirming 2023 EBITDA guidance of EUR 320-420 million.
investor_presentation
35 Pages
earnings
22 Pages
Lam Research Corporation
Teva Pharmaceutical Q4 2022 Earnings Results
earningsearnings
46 Pages
Teva Pharmaceutical Industries Ltd.
Nexteer Automotive Q1 2022 Earnings Update
earningsearnings
9 Pages
Nexteer Automotive Corporation
Cameco Q3 2016 Earnings Results Conference
earningsearnings
10 Pages
Cameco Corporation